Odyssey Therapeutics ODTX
$16.96 −$1.38 (-7.52%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $16.96 0.00%
Open$17.65
Prev close$18.34
Day range$16.46 – $18.08
Volume677.8K
Market cap$815.23M
P/E (TTM)–
Dividend yield–
ODTX Stock News
Headlines matching Odyssey Therapeutics or the ODTX ticker, most recent first.
- H.C. Wainwright Maintains Odyssey Therapeutics(ODTX.US) With Buy Rating, Maintains Target Price $44
- H.C. Wainwright Keeps Their Buy Rating on Odyssey Therapeutics, Inc. (ODTX)
- Analysts Offer Insights on Healthcare Companies: Biodesix (BDSX), Pacific Biosciences (PACB) and Odyssey Therapeutics, Inc. (ODTX)
- Wedbush Maintains Odyssey Therapeutics(ODTX.US) With Buy Rating, Maintains Target Price $30
- H.C. Wainwright Initiates Odyssey Therapeutics(ODTX.US) With Buy Rating, Announces Target Price $44
- TD Cowen Maintains Odyssey Therapeutics(ODTX.US) With Buy Rating
- Analysts Offer Insights on Healthcare Companies: Odyssey Therapeutics, Inc. (ODTX), Metagenomi, Inc. (MGX) and Autolus Therapeutics (AUTL)
- J.P. Morgan Maintains Odyssey Therapeutics(ODTX.US) With Buy Rating, Raises Target Price to $29 Positive
- A Quick Look at Today's Ratings for Odyssey Therapeutics(ODTX.US), With a Forecast Between $16.96 to $40
- Analysts Offer Insights on Healthcare Companies: Odyssey Therapeutics, Inc. (ODTX), Capricor Therapeutics (CAPR) and Medtronic (MDT)
- Oppenheimer Maintains Odyssey Therapeutics(ODTX.US) With Buy Rating, Maintains Target Price $40
- H.C. Wainwright Initiates Odyssey Therapeutics(ODTX.US) With Buy Rating, Announces Target Price $40
- Wedbush Maintains Odyssey Therapeutics(ODTX.US) With Buy Rating, Maintains Target Price $30
- Oppenheimer Maintains Odyssey Therapeutics(ODTX.US) With Buy Rating, Maintains Target Price $40
- Analysts Offer Insights on Healthcare Companies: Alcon (ALC) and Odyssey Therapeutics, Inc. (ODTX)
No comments yet — be the first to weigh in on ODTX.
Sign in to join the discussion.